Panel Discussion by Endpoint News featuring BCA SVP of Advanced Therapies
Watch a fascinating panel discussion hosted by Endpoints News involving our Sr. VP of Advanced Therapies, Lee Buckler, and other industry colleagues discussing what it will take to deliver cell and gene therapies at scale.
New Update of BCA Advanced Therapies Capabilities Deck
We have an updated Advanced Therapies Capabilities Deck! We are proud to share this new deck, showcasing our national but hyper-local network of facilities throughout the country offering apheresis collection, cryopreservation, and ISO-7 clean room capacity for companies in the advanced therapy, cell and gene therapy sector. BCA ATN Capabilities deck (2023-09-25).pdf
BCA Launches a New Video Showcasing Its National Network
We have a new video showcasing BCA and its national network of centers supplying blood, red blood cells, platelets, plasma, to hospitals throughout the country and other therapeutic cells for further cell therapy manufacturing to biopharmaceutical companies with developing or commercial cell therapies. The video can be found here: BCA – Who We Are (1) […]
BCA Sr. Vice President of Advanced Therapies to Speak at the Immuno-Oncology Summit
Lee Buckler sets off to speak on decentralized manufacturing and allogenic approaches at the Immuno-Oncology Summit 2023.
Decentralization of Manufacturing Cell Therapies
Discussing the decentralization of manufacturing cell therapies
ISCT 2023 Session “Automation and Digitalization in Manufacturing” Highlights
Outstanding ISCT 2023 session in Paris, France “Automation and Digitalization in Manufacturing” moderated by Shannon Eaker with J. Kelly Ganjei, Edwin Stone, and Jeet Sarkar. What are the barriers to the adoption of automation and digitization in manufacturing and what are the range of explore potential solutions? Panel makes the point that the industry currently […]
Quick Facts about Blood Centers of America and its Advanced Therapies Network
Four facts about BCA’s Advanced Therapies Network BCA centers generate >$3B in revenue annually managing >50% of the country’s supply of blood and blood components from >500 facilities owned by ~65 centers in 43 states supplying biomaterials from >3.5 million annual donors to thousands of hospitals. BCA additionally represents access to 7 cord blood banks, […]
BioBridge Global Profiled 2023 Affiliate Member of AATB
BCA member, BioBridge Global, becomes an affiliate member of AATB BCA is thrilled to announce that BioBridge Global, one of our member centers, has been profiled by our sister organization AATB. BioBridge Global is a nonprofit organization that utilizes advanced therapies to improve and save patients’ lives. Blood Centers of America is proud of its […]
Legend Biotech and The Janssen Pharmaceutical Companies of Johnson & Johnson Seek Approval of Carvykti
Legend Biotech and The Janssen Pharmaceutical Companies of Johnson & Johnson seek approval to get their Carvykti CAR T-Cell multiple myeloma treatment to more patients With its latest FDA filing, Legend Biotech and The Janssen Pharmaceutical Companies of Johnson & Johnson seeks approval to get their Carvykti CART-Cell treatment to more patients. After gaining approval […]
FDA Accepts Iovance Biotherapeutics’ BLA Submission
Iovance Biotherapeutics, Inc. announces the FDA acceptance of its BLA submission In another step toward commercial approval, Iovance Biotherapeutics, Inc. announced yesterday that with the FDA acceptance of its BLA submission for its lifileucel cell therapy and its Priority Review status, its PDUFA date is November 25 of this year. Furthermore, the FDA is not […]